[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100560723":3},{"organization":4,"armGroups":7,"interventions":34,"overallOfficials":10,"centralContacts":40,"locations":46,"responsibleParty":63,"collaborators":10,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":87,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Second Xiangya Hospital of Central South University","OTHER",[8,14,18,22,26,30],{"label":9,"type":10,"description":11,"interventionNames":12},"PMNP-Healthy Norms",null,"Healthy Norms",[13],"Drug: Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids",{"label":15,"type":10,"description":16,"interventionNames":17},"PMNP-Subclinical high-risk","Subclinical high-risk",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"PMNP-Schizophrenia and Psychosis","Schizophrenia and Psychosis patient",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"PMNP-MDD","major depressive disorder patient",[13],{"label":27,"type":10,"description":28,"interventionNames":29},"PMNP-ASD","autism spectrum disorder patient",[13],{"label":31,"type":10,"description":32,"interventionNames":33},"PMNP-BD","bipolar disorder patient",[13],[35],{"type":36,"name":37,"description":38,"armGroupLabels":39,"otherNames":10},"DRUG","Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids","Patients with mental disorders should take the appropriate medicine as prescribed by the doctor，and the health norms are not required to take medicine.This study will not interfere with the medication regimen of doctors.",[27,31,9,23,19,15],[41],{"name":42,"role":43,"phone":44,"phoneExt":10,"email":45},"Yunzhi Pan","CONTACT","15074818197","panyunzhi@csu.edu.cn",[47],{"facility":48,"status":49,"city":50,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"The Second Xiangya hospital of central south univerity","RECRUITING","Changsha","Hunan","410000","China","CN",{"type":56,"coordinates":57},"Point",[58,59],112.97087,28.19874,{"lat":59,"lon":58},[62],{"name":42,"role":43,"phone":44,"phoneExt":10,"email":45},{"type":64,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","mingjun Zhong","Principal Investigator","100560723","psychiatric-multi-omics-and-neuroimaging-project-100560723",false,"NCT06580860","Psychiatric Multi-omics and Neuroimaging Project","Psychiatric Multi-omics and Neuroimaging Project Database","PMNP","Inclusion Criteria:\n\n* Age: 13-35 years old(Patients with healthy siblings can be extended to 14-35 years of age)\n* Course of disease: \\\u003C24 months\n* Priority is given to patients who have never taken medicine or duration of drug use \\\u003C 2 weeks\n* No nuclear magnetic contraindications.\n\nExclusion Criteria:\n\n* Family history of psychotic disorders, history of psychoactive substances abuse, alcohol dependence, or nicotine dependence\n* Have a major physical disease or infectious disease\n* History of coma and serious neurological disease 4.MRI contraindications.",true,"ALL","13 Years","35 Years",{"count":80,"type":81},1899,"ESTIMATED","OBSERVATIONAL","This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.",[85,86],"Mental Disorders","Healthy Control",[88,89,90,91,92,93],"schizophrenia","major depressive disorder","autism spectrum disorder","bipolar disorder","magnetic resonance imaging","multi-omics","2026-03-11",{"date":96,"type":97},"2026-03-13","ACTUAL",{"date":99,"type":97},"2016-01",{"date":101,"type":81},"2027-01",{"name":65,"class":6},1]